Deimination restores inner retinal visual function in murine demyelinating disease

Journal of Clinical Investigation

Volumn 123, Issue 2, 2013, Pages 646-656

  Enriquez Algeciras, Mabel ^a   Ding, Di ^a,b   Mastronardi, Fabrizio G ^c   Marc, Robert E ^d   Porciatti, Vittorio ^a,e   Bhattacharya, Sanjoy K ^a,b,e  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c John A Moran Eye Center ^*  (Canada)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; REFBP2 PROTEIN; RNA BINDING PROTEIN; SMALL INTERFERING RNA; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLS; CONTROLLED STUDY; DEIMINATION; DENDRITE; DISEASE ASSOCIATION; DOWN REGULATION; ELECTRORETINOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; MULTIPLE SCLEROSIS; NERVE CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; RETINA; RETINA GANGLION CELL; RNA BINDING; SYNTHESIS; TANDEM MASS SPECTROMETRY; VISUAL IMPAIRMENT;

AGED; AMINO ACID SEQUENCE; ANIMALS; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; NUCLEAR PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RETINA; RETINAL GANGLION CELLS; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS; VISION DISORDERS; VISION, OCULAR;

EID: 84873343663     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI64811     Document Type: Article

References (42)

1. Hagemeier K, Bruck W, Kuhlmann T. Multiple sclerosis - remyelination failure as a cause of disease progression. Histol Histopathol. 2012;27(3):277-287.
2. Kolappan M, et al. Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis. J Neurol. 2009;256(3):305-319.
3. Lassman H. What drives disease in multiple sclerosis: Inflammation or neurodegeneration? Clin Exp Neuroimmunol. 2010;1:2-11.
4. Ziemssen T. Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis. J Neurol. 2005;5:v38-v45.
5. Popko B, Baerwald KD. Oligodendroglial response to the immune cytokine interferon gamma. Neurochem Res. 1999;24(2):331-338.
6. Xu J, Sun SW, Naismith RT, Snyder AZ, Cross AH, Song SK. Assessing optic nerve pathology with diffusion MRI: from mouse to human. NMR Biomed. 2008;21(9):928-940.
7. Enriquez-Algeciras M, et al. Evaluation of a transgenic mouse model of multiple sclerosis with noninvasive methods. Invest Ophthalmol Vis Sci. 2011;52(5):2405-2411.
8. Holder GE. Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis. Prog Retin Eye Res. 2001;20(4):531-561.
9. Holder GE, Gale RP, Acheson JF, Robson AG. Electrodiagnostic assessment in optic nerve disease. Curr Opin Neurol. 2009;22(1):3-10.
10. Walter SD, et al. Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology. 2012;119(6):1250-1257.
11. Gupta AA, Ding D, Lee RK, Levy RB, Bhattacharya SK. Spontaneous ocular and neurologic deficits in transgenic mouse models of multiple sclerosis and noninvasive investigative modalities: a review. Invest Ophthalmol Vis Sci. 2012;53(2):712-724.
12. Johnson RS, Roder JC, Riordan JR. Over-expression of the DM-20 myelin proteolipid causes central nervous system demyelination in transgenic mice. J Neurochem. 1995;64(3):967-976.
13. Mastronardi FG, Ackerley CA, Arsenault L, Roots BI, Moscarello MA. Demyelination in a transgenic mouse: a model for multiple sclerosis. J Neurosci Res. 1993;36(3):315-324.
14. Vossenaar ER, Zendman AJ, Van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays. 2003;25(11):1106-1118.
15. Bhattacharya SK. Retinal deimination in aging and disease. IUBMB Life. 2009;61(5):504-509.
16. Moscarello MA, Wood DD, Ackerley C, Boulias C. Myelin in multiple sclerosis is developmentally immature. J Clin Invest. 1994;94(1):146-154.
17. Mastronardi FG, Noor A, Wood DD, Paton T, Moscarello MA. Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated. J Neurosci Res. 2007;85(9):2006-2016.
18. Pritzker LB, Joshi S, Gowan JJ, Harauz G, Moscarello MA. Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry. 2000;39(18):5374-5381.
19. Marc RE, Jones BW. Molecular phenotyping of retinal ganglion cells. J Neurosci. 2002;22(2):413-427.
20. Porciatti V. The mouse pattern electroretinogram. Doc Ophthalmol. 2007;115(3):145-153.
21. Golovanov AP, Hautbergue GM, Tintaru AM, Lian LY, Wilson SA. The solution structure of REF2-I reveals interdomain interactions and regions involved in binding mRNA export factors and RNA. RNA. 2006;12(11):1933-1948.
22. Rodrigues JP, Rode M, Gatfield D, Blencowe BJ, Carmo-Fonseca M, Izaurralde E. REF proteins mediate the export of spliced and unspliced mRNAs from the nucleus. Proc Natl Acad Sci U S A. 2001;98(3):1030-1035.
23. Ding D, Enriquez-Algeciras M, Dave KR, Perez-Pinzon M, Bhattacharya SK. The role of deimination in ATP5b mRNA transport in a transgenic mouse model of multiple sclerosis. EMBO Rep. 2012;13(3):230-236.
24. Stutz F, et al. REF, an evolutionary conserved family of hnRNP-like proteins, interacts with TAP/Mex67p and participates in mRNA nuclear export. RNA. 2000;6(4):638-650.
25. Osen-Sand A, et al. Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo. Nature. 1993;364(6436):445-448.
26. Bassell GJ, Singer RH, Kosik KS. Association of poly (A) mRNA with microtubules in cultured neurons. Neuron. 1994;12(3):571-582.
27. Gingras AC, Raught B, Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem. 1999;68:913-963.
28. Sutton MA, Schuman EM. Dendritic protein synthesis, synaptic plasticity, and memory. Cell. 2006;127(1):49-58.
29. Shelly M, Cancedda L, Heilshorn S, Sumbre G, Poo MM. LKB1/STRAD promotes axon initiation during neuronal polarization. Cell. 2007;129(3):565-577.
30. Sun D, et al. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol. 2001;166(12):7579-7587.
31. John SW, et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci. 1998;39(6):951-962.
32. Howell GR, et al. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J Cell Biol. 2007;179(7):1523-1537.
33. Chang EE, Goldberg JL. Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement. Ophthalmology. 2012;119(5):979-986.
34. Bhattacharya SK, Crabb JS, Bonilha VL, Gu X, Takahara H, Crabb JW. Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis. Invest Ophthalmol Vis Sci. 2006;47(6):2508-2514.
35. Kashiwagi K, Iizuka Y, Tanaka Y, Araie M, Suzuki Y, Tsukahara S. Molecular and cellular reactions of retinal ganglion cells and retinal glial cells under centrifugal force loading. Invest Ophthalmol Vis Sci. 2004;45(10):3778-3786.
36. Algeciras ME, Takahara H, Bhattacharya SK. Mechanical stretching elevates peptidyl arginine deiminase 2 expression in astrocytes. Curr Eye Res. 2008;33(11):994-1001.
37. Bhattacharya SK, Sinicrope B, Rayborn ME, Hollyfield JG, Bonilha VL. Age-related reduction in retinal deimination levels in the F344BN rat. Aging Cell. 2008;7(3):441-444.
38. Barres BA, Silverstein BE, Corey DP, Chun LL. Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning. Neuron. 1988;1(9):791-803.
39. Huettner JE, Baughman RW. Primary culture of identified neurons from the visual cortex of postnatal rats. J Neurosci. 1986;6(10):3044-3060.
40. Wysocki LJ, Sato VL. "Panning" for lymphocytes: a method for cell selection. Proc Natl Acad Sci U S A. 1978;75(6):2844-2848.
41. Porciatti V, Saleh M, Nagaraju M. The pattern electroretinogram as a tool to monitor progressive retinal ganglion cell dysfunction in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci. 2007;48(2):745-751.
42. Anderson JR, et al. A computational framework for ultrastructural mapping of neural circuitry. PLoS Biol. 2009;7(3):e1000074.